201 related articles for article (PubMed ID: 28398584)
1. Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.
Vitucci M; Irvin DM; McNeill RS; Schmid RS; Simon JM; Dhruv HD; Siegel MB; Werneke AM; Bash RE; Kim S; Berens ME; Miller CR
Neuro Oncol; 2017 Sep; 19(9):1237-1247. PubMed ID: 28398584
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.
Irvin DM; McNeill RS; Bash RE; Miller CR
Brain Pathol; 2017 Jan; 27(1):36-50. PubMed ID: 26762242
[TBL] [Abstract][Full Text] [Related]
3. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Wakimoto H; Tanaka S; Curry WT; Loebel F; Zhao D; Tateishi K; Chen J; Klofas LK; Lelic N; Kim JC; Dias-Santagata D; Ellisen LW; Borger DR; Fendt SM; Vander Heiden MG; Batchelor TT; Iafrate AJ; Cahill DP; Chi AS
Clin Cancer Res; 2014 Jun; 20(11):2898-909. PubMed ID: 24714777
[TBL] [Abstract][Full Text] [Related]
4. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
6. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.
Schmid RS; Simon JM; Vitucci M; McNeill RS; Bash RE; Werneke AM; Huey L; White KK; Ewend MG; Wu J; Miller CR
Neuro Oncol; 2016 Jul; 18(7):962-73. PubMed ID: 26826202
[TBL] [Abstract][Full Text] [Related]
7. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
8. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
Ozawa T; Riester M; Cheng YK; Huse JT; Squatrito M; Helmy K; Charles N; Michor F; Holland EC
Cancer Cell; 2014 Aug; 26(2):288-300. PubMed ID: 25117714
[TBL] [Abstract][Full Text] [Related]
9. Developmental origins and oncogenic pathways in malignant brain tumors.
Lu QR; Qian L; Zhou X
Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
[TBL] [Abstract][Full Text] [Related]
10. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
[TBL] [Abstract][Full Text] [Related]
11. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
12. Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas.
Park CK; Park I; Lee S; Sun CH; Koh Y; Park SH; Kim JE; Yun H; Lee SH
Oncotarget; 2015 Dec; 6(41):43653-66. PubMed ID: 26524630
[TBL] [Abstract][Full Text] [Related]
13. Extrachromosomal driver mutations in glioblastoma and low-grade glioma.
Nikolaev S; Santoni F; Garieri M; Makrythanasis P; Falconnet E; Guipponi M; Vannier A; Radovanovic I; Bena F; Forestier F; Schaller K; Dutoit V; Clement-Schatlo V; Dietrich PY; Antonarakis SE
Nat Commun; 2014 Dec; 5():5690. PubMed ID: 25471132
[TBL] [Abstract][Full Text] [Related]
14. Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J; Saxe DF; Neill SG; Olson JJ; Crocker IR; Curran WJ; Shu HG
Sci Rep; 2020 Apr; 10(1):7355. PubMed ID: 32355162
[TBL] [Abstract][Full Text] [Related]
15. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
[TBL] [Abstract][Full Text] [Related]
17. Somatic intronic microsatellite loci differentiate glioblastoma from lower-grade gliomas.
Karunasena E; McIver LJ; Rood BR; Wu X; Zhu H; Bavarva JH; Garner HR
Oncotarget; 2014 Aug; 5(15):6003-14. PubMed ID: 25153720
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Koga T; Chaim IA; Benitez JA; Markmiller S; Parisian AD; Hevner RF; Turner KM; Hessenauer FM; D'Antonio M; Nguyen ND; Saberi S; Ma J; Miki S; Boyer AD; Ravits J; Frazer KA; Bafna V; Chen CC; Mischel PS; Yeo GW; Furnari FB
Nat Commun; 2020 Jan; 11(1):550. PubMed ID: 31992716
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
[TBL] [Abstract][Full Text] [Related]
20.
Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
